Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samia Mora

Showing results (231-240 of 260) with videos related to

Pageof 26
Sort By:
Clinical Chemistry|May 29, 2016
Fasting Is Not Routinely Required for Determination of a Lipid Profile: Clinical and Laboratory Implications Including Flagging at Desirable Concentration Cutpoints-A Joint Consensus Statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory MedicineBørge G Nordestgaard, Anne Langsted, Samia Mora, et al.
Genetic Epidemiology|January 7, 2025
Refinement of a Published Gene-Physical Activity Interaction Impacting HDL-Cholesterol: Role of Sex and Lipoprotein SubfractionsKenneth E Westerman, Tuomas O Kilpeläinen, Magdalena Sevilla-Gonzalez, et al.
Plos One|December 1, 2016
Association of N-Linked Glycoprotein Acetyls and Colorectal Cancer Incidence and MortalityPaulette D Chandler, Akintunde O Akinkuolie, Deirdre K Tobias, et al.
Proteomics|May 22, 2022
Stability and reproducibility of proteomic profiles in epidemiological studies: comparing the Olink and SOMAscan platformsDanielle E Haslam, Jun Li, Simon T Dillon, et al.
Clinical Chemistry|May 16, 2018
Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLMMichel R Langlois, M John Chapman, Christa Cobbaert, et al.
Circulation Research|July 21, 2022
Association of Physical Activity With Bioactive Lipids and Cardiovascular EventsRosangela A Hoshi, Yanyan Liu, Heike Luttmann-Gibson, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|April 2, 2022
Red blood cell fatty acid patterns from 7 countries: Focus on the Omega-3 indexJan Philipp Schuchardt, Marianna Cerrato, Martina Ceseri, et al.
JAMA|March 29, 2012
Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysisS Matthijs Boekholdt, Benoit J Arsenault, Samia Mora, et al.
Current Vascular Pharmacology|January 27, 2026
Hellenic Postprandial Lipemia Study (HPLS): A Prospective Cohort Trial on the Effect of Statins on Postprandial HypertriglyceridemiaGenovefa D Kolovou, Theodoros Katsikas, Petros Kalogeropoulos, et al.
Circulation|August 23, 2013
Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysisS Matthijs Boekholdt, Benoit J Arsenault, G Kees Hovingh, et al.
Pageof 26

Showing results (231-240 of 260) with videos related to

Sort By:
Pageof 26
Clinical Chemistry|May 29, 2016
Fasting Is Not Routinely Required for Determination of a Lipid Profile: Clinical and Laboratory Implications Including Flagging at Desirable Concentration Cutpoints-A Joint Consensus Statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory MedicineBørge G Nordestgaard, Anne Langsted, Samia Mora, et al.
Genetic Epidemiology|January 7, 2025
Refinement of a Published Gene-Physical Activity Interaction Impacting HDL-Cholesterol: Role of Sex and Lipoprotein SubfractionsKenneth E Westerman, Tuomas O Kilpeläinen, Magdalena Sevilla-Gonzalez, et al.
Plos One|December 1, 2016
Association of N-Linked Glycoprotein Acetyls and Colorectal Cancer Incidence and MortalityPaulette D Chandler, Akintunde O Akinkuolie, Deirdre K Tobias, et al.
Proteomics|May 22, 2022
Stability and reproducibility of proteomic profiles in epidemiological studies: comparing the Olink and SOMAscan platformsDanielle E Haslam, Jun Li, Simon T Dillon, et al.
Clinical Chemistry|May 16, 2018
Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLMMichel R Langlois, M John Chapman, Christa Cobbaert, et al.
Circulation Research|July 21, 2022
Association of Physical Activity With Bioactive Lipids and Cardiovascular EventsRosangela A Hoshi, Yanyan Liu, Heike Luttmann-Gibson, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|April 2, 2022
Red blood cell fatty acid patterns from 7 countries: Focus on the Omega-3 indexJan Philipp Schuchardt, Marianna Cerrato, Martina Ceseri, et al.
JAMA|March 29, 2012
Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysisS Matthijs Boekholdt, Benoit J Arsenault, Samia Mora, et al.
Current Vascular Pharmacology|January 27, 2026
Hellenic Postprandial Lipemia Study (HPLS): A Prospective Cohort Trial on the Effect of Statins on Postprandial HypertriglyceridemiaGenovefa D Kolovou, Theodoros Katsikas, Petros Kalogeropoulos, et al.
Circulation|August 23, 2013
Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysisS Matthijs Boekholdt, Benoit J Arsenault, G Kees Hovingh, et al.
Pageof 26